Lobbying Spend
—
Filings
29
Firms Hired
1
Active Period
2019–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
PREVENT HPV Cancers Act of 2021
2022 · fourth_quarter · Firm: MONUMENT ADVOCACY
Issues related to healthcare, cancer research, Medicare payment systems, treatment cost and access for cancer patients, COVID-19 response, including vaccinations, telehealth, payment parity; H.R. 1550 - PREVENT HPV Cancers Act of 2021
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1550
PREVENT HPV Cancers Act of 2021
2022 · third_quarter · Firm: MONUMENT ADVOCACY
Issues related to healthcare, cancer research, Medicare payment systems, treatment cost and access for cancer patients, COVID-19 response, including vaccinations, telehealth, payment parity; H.R. 1550 - PREVENT HPV Cancers Act of 2021
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1550
PREVENT HPV Cancers Act of 2021
2022 · second_quarter · Firm: MONUMENT ADVOCACY
Issues related to healthcare, cancer research, Medicare payment systems, treatment cost and access for cancer patients, COVID-19 response, including vaccinations, telehealth, payment parity; H.R. 1550 - PREVENT HPV Cancers Act of 2021
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1550
PREVENT HPV Cancers Act of 2021
2022 · first_quarter · Firm: MONUMENT ADVOCACY
Issues related to healthcare, cancer research, Medicare payment systems, treatment cost and access for cancer patients, COVID-19 response, including vaccinations, telehealth, payment parity; H.R. 1550 - PREVENT HPV Cancers Act of 2021
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1550
Issues related to healthcare, cancer research, Medicare payment systems, treatment cost and access for cancer patients, COVID-19 response, including vaccinations, telehealth, rural broadband, payment parity, and H.R. 3630 and S. 1315, The Lymphedema Treatment Act
Client expense: — · Firm income: $60,000
Matched citations: H.R. 3630
Issues related to healthcare, cancer research, Medicare payment systems, treatment cost and access for cancer patients, COVID-19 response, including vaccinations, telehealth, rural broadband, payment parity, and H.R. 3630 and S. 1315, The Lymphedema Treatment Act
Client expense: — · Firm income: $60,000
Matched citations: S. 1315
Source: Senate LDA